Abstract
Get full access to this article
View all access options for this article.
References
1.U.S. Food and Drug Administration (FDA) . FDA Investigating Deaths Due to Acute Liver Failure in Non-ambulatory Duchenne Muscular Dystrophy Patients Following ELEVIDYS . June 24, 2025 . Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-deaths-due-acute-liver-failure-non-ambulatory-duchenne-muscular-dystrophy-patients [Last accessed:
July 3 , 2025
].
2.Sarepta Therapeutics . Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne . June 15, 2025 . Available from: https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-provides-safety-update-elevidys-and-initiates-steps [Last accessed:
July 2 , 2025
].
3.
Feuerstein
A
,
Herper
M
,
Lawrence
L
, et al. Disagreements over Duchenne therapy, management style may have led to ouster of key FDA official . STAT News ; June 20,2025 . Available from: https://www.statnews.com/2025/06/20/fda-ouster-top-gene-therapy-official-nicole-verdun-placed-on-leave-after-review-committee-canceled/ [Last accessed:
July 2 , 2025
].
4.
Philippidis
A
. StockWatch: CGT Stocks Fall on FDA Therapeutic Products Upheaval . Genetic Engineering & Biotechnology News ; June 22, 2025 . Available from: https://www.genengnews.com/topics/genome-editing/stockwatch-cgt-stocks-fall-on-fda-therapeutic-products-upheaval/ [Last accessed:
July 2 , 2025
].
5.4D Molecular Therapeutics . 4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution . July 2, 2025 . Available from: https://4dmt.gcs-web.com/news-releases/news-release-details/4dmt-announces-accelerated-4d-150-phase-3-development-wet-amd [Last accessed:
July 3 , 2025
].
6.ProBio . ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy . June 27, 2025 . Available from: https://www.probiocdmo.com/probio-opens-new-facility-in-hopewell.html [Last accessed:
July 2 , 2025
].
7.Sensorion . Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial . July 1, 2025 . Available from: https://s27.q4cdn.com/232015521/files/doc_news/Sensorion-Announces-Preliminary-Positive-Data-from-the-First-Cohort-of-the-Audiogene-Phase-12-Gene-Therapy-Clinical-Trial-2025.pdf [Last accessed:
July 2 , 2025
].
8.Neurogene . Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome . June 30, 2025 . Available from: https://ir.neurogene.com/news-releases/news-release-details/neurogene-announces-registrational-trial-design-emboldentm-study [Last accessed:
July 3 , 2025
].